Stefanos Farfaras1,2, Leyla Roshani3, Jan Mulder4, Nicholas Mitsios4, Erling K Hallström3,5, Jüri-Toomas Kartus3,5,6. 1. Department of Research and Development, NU-Hospital Group Trollhättan/Uddevalla, 451 80, Uddevalla, Sweden. farfarasst@hotmail.com. 2. Department of Orthopedics, Institute of Clinical Science, Sahlgrenska Academy Gothenburg University, Gothenburg, Sweden. farfarasst@hotmail.com. 3. Department of Research and Development, NU-Hospital Group Trollhättan/Uddevalla, 451 80, Uddevalla, Sweden. 4. Department of Neurosciences, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. 5. Department of Orthopedics, NU-Hospital Group Trollhättan/Uddevalla, Uddevalla, Sweden. 6. Department of Orthopedics, Institute of Clinical Science, Sahlgrenska Academy Gothenburg University, Gothenburg, Sweden.
Abstract
PURPOSE: To analyze biopsy samples from the subscapularis tendon and from the joint capsule from male patients with subacromial impingement syndrome and compare them with samples from male patients with post-traumatic recurrent shoulder instability, to detect increased inflammatory activity that might be present inside the humeroscapular joint. METHODS: Twenty male patients scheduled for surgery for either subacromial decompression or Bankart reconstruction were included. Four biopsies from each patient were obtained during surgery from the capsule and the subscapularis tendon. Each specimen was analyzed for TNF-α, IL-6, CD-3 and CD-72. Multiplex fluorescence immunohistochemistry was performed on histological samples from the capsule and tendon to demonstrate the level of inflammatory markers. Fluorescence microscope images were acquired using an automated scanning system. On each slide, the number of pixels was registered and used in the analyses. RESULTS: The subacromial impingement syndrome group comprised eight patients, median age 53 (45-74) years, while the instability group 12, median age 27 (22-48) years (p < 0.00001). The amount of IL-6 and TNF-α was significantly higher in the subscapularis tendon of the patients with subacromial impingement syndrome compared with instability patients (p = 0.0015 and p = 0.0008 respectively). In the capsular samples, significantly higher amount of TNF-α and CD-72 was found in patients with subacromial impingement syndrome compared with instability patients (p < 0.0001 for both). On the other hand, the amount of CD-3 was significantly higher in the instability group (p = 0.0013). CONCLUSIONS: This study provides evidence that an extended inflammatory process is present, not only in the subacromial bursa but also in the glenohumeral joint in patients with subacromial impingement syndrome. LEVEL OF EVIDENCE: Level III. CLINICAL RELEVANCE: To develop a treatment targeted towards intra-articular inflammatory cytokines appears appealing.
PURPOSE: To analyze biopsy samples from the subscapularis tendon and from the joint capsule from male patients with subacromial impingement syndrome and compare them with samples from male patients with post-traumatic recurrent shoulder instability, to detect increased inflammatory activity that might be present inside the humeroscapular joint. METHODS: Twenty male patients scheduled for surgery for either subacromial decompression or Bankart reconstruction were included. Four biopsies from each patient were obtained during surgery from the capsule and the subscapularis tendon. Each specimen was analyzed for TNF-α, IL-6, CD-3 and CD-72. Multiplex fluorescence immunohistochemistry was performed on histological samples from the capsule and tendon to demonstrate the level of inflammatory markers. Fluorescence microscope images were acquired using an automated scanning system. On each slide, the number of pixels was registered and used in the analyses. RESULTS: The subacromial impingement syndrome group comprised eight patients, median age 53 (45-74) years, while the instability group 12, median age 27 (22-48) years (p < 0.00001). The amount of IL-6 and TNF-α was significantly higher in the subscapularis tendon of the patients with subacromial impingement syndrome compared with instability patients (p = 0.0015 and p = 0.0008 respectively). In the capsular samples, significantly higher amount of TNF-α and CD-72 was found in patients with subacromial impingement syndrome compared with instability patients (p < 0.0001 for both). On the other hand, the amount of CD-3 was significantly higher in the instability group (p = 0.0013). CONCLUSIONS: This study provides evidence that an extended inflammatory process is present, not only in the subacromial bursa but also in the glenohumeral joint in patients with subacromial impingement syndrome. LEVEL OF EVIDENCE: Level III. CLINICAL RELEVANCE: To develop a treatment targeted towards intra-articular inflammatory cytokines appears appealing.
Authors: Theodore A Blaine; Yang-Soo Kim; Ilya Voloshin; Darwin Chen; Koko Murakami; Seong-Sil Chang; Robert Winchester; Francis Y Lee; Regis J O'keefe; Louis U Bigliani Journal: J Shoulder Elbow Surg Date: 2005 Jan-Feb Impact factor: 3.019
Authors: Theodore A Blaine; Mindy A Cote; Al Proto; Mary Mulcahey; Francis Y Lee; Louis U Bigliani Journal: J Orthop Res Date: 2011-04-11 Impact factor: 3.494
Authors: S D M Bot; J M van der Waal; C B Terwee; D A W M van der Windt; F G Schellevis; L M Bouter; J Dekker Journal: Ann Rheum Dis Date: 2005-01 Impact factor: 19.103
Authors: Luigi Ferrucci; Annamaria Corsi; Fulvio Lauretani; Stefania Bandinelli; Benedetta Bartali; Dennis D Taub; Jack M Guralnik; Dan L Longo Journal: Blood Date: 2004-11-30 Impact factor: 22.113
Authors: Moeed Akbar; Michael McLean; Emma Garcia-Melchor; Lindsay An Crowe; Paul McMillan; Umberto G Fazzi; David Martin; Angus Arthur; James H Reilly; Iain B McInnes; Neal L Millar Journal: PLoS One Date: 2019-04-23 Impact factor: 3.240
Authors: Gonzalo Para-García; Ana María García-Muñoz; José Francisco López-Gil; Juan Diego Ruiz-Cárdenas; Ana Isabel García-Guillén; Francisco Javier López-Román; Silvia Pérez-Piñero; María Salud Abellán-Ruiz; Fernando Cánovas; Desirée Victoria-Montesinos Journal: Int J Environ Res Public Health Date: 2022-09-02 Impact factor: 4.614